Shanghai Pharmaceuticals Holding Co., Ltd
SHPMY
$7.34
-$0.26-3.42%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.89B | 9.52B | 10.33B | 9.73B | 9.73B |
| Total Other Revenue | -- | 144.90M | -67.22M | 66.54M | -- |
| Total Revenue | 10.89B | 9.66B | 10.27B | 9.80B | 9.73B |
| Cost of Revenue | 9.72B | 8.54B | 9.22B | 8.73B | 8.73B |
| Gross Profit | 1.17B | 1.12B | 1.04B | 1.07B | 997.62M |
| SG&A Expenses | 703.82M | 679.64M | 683.27M | 674.93M | 596.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 19.12M | 38.27M | 18.11M | 13.84M | 19.15M |
| Total Operating Expenses | 10.51B | 9.38B | 10.00B | 9.48B | 9.42B |
| Operating Income | 380.06M | 287.66M | 262.21M | 313.60M | 313.32M |
| Income Before Tax | 349.97M | 214.66M | 206.40M | 645.57M | 295.96M |
| Income Tax Expenses | 82.33M | 75.35M | 67.89M | 181.65M | 70.46M |
| Earnings from Continuing Operations | 267.64M | 139.31M | 138.51M | 463.92M | 225.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -62.54M | -57.85M | -42.36M | -31.64M | -42.22M |
| Net Income | 205.10M | 81.46M | 96.15M | 432.28M | 183.27M |
| EBIT | 380.06M | 287.66M | 262.21M | 313.60M | 313.32M |
| EBITDA | 452.03M | 357.84M | 315.38M | 379.18M | 371.66M |
| EPS Basic | 0.06 | 0.02 | 0.03 | 0.12 | 0.05 |
| Normalized Basic EPS | 0.04 | 0.02 | 0.03 | 0.11 | 0.04 |
| EPS Diluted | 0.06 | 0.02 | 0.03 | 0.12 | 0.05 |
| Normalized Diluted EPS | 0.04 | 0.02 | 0.03 | 0.11 | 0.04 |
| Average Basic Shares Outstanding | 3.71B | 3.72B | 3.69B | 3.71B | 3.71B |
| Average Diluted Shares Outstanding | 3.71B | 3.72B | 3.69B | 3.71B | 3.71B |
| Dividend Per Share | -- | 0.05 | 0.00 | 0.02 | -- |
| Payout Ratio | 58.56% | 73.74% | 220.04% | 8.61% | 44.31% |